Sompob Saralamba
Overview
Explore the profile of Sompob Saralamba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Astley J, Saralamba S, Poovorawan K, White L, Aguas R, Pan-Ngum W
PLoS One
. 2024 Oct;
19(10):e0309313.
PMID: 39413060
Background: Hepatitis C Virus is endemic to many areas of Thailand, whose population structure is tending towards older age groups as birth rate and mortality decrease. With around 790,000 cases...
2.
Swangsri T, Reamtong O, Saralamba S, Rakthong P, Thaenkham U, Saralamba N
Pharm Biol
. 2024 Aug;
62(1):666-675.
PMID: 39205473
Context: Plant peptides garner attention for their potential antimicrobial properties amid the rising concern over antibiotic-resistant bacteria. Objective: This study investigates the antibacterial potential of crude peptide extracts from 27...
3.
Saralamba S, Simpson J, White N
J Antimicrob Chemother
. 2024 Jan;
79(3):692.
PMID: 38252889
No abstract available.
4.
Srimokla O, Pan-Ngum W, Khamsiriwatchara A, Padungtod C, Tipmontree R, Choosri N, et al.
Malar J
. 2024 Jan;
23(1):11.
PMID: 38191421
Background: Malaria continues to pose a significant health threat. Rapid identification of malaria infections and the deployment of active surveillance tools are crucial for achieving malaria elimination in regions where...
5.
Saralamba S, Simpson J, Choosri N, White L, Pan-Ngum W, Dondorp A, et al.
J Antimicrob Chemother
. 2023 Jul;
78(9):2192-2202.
PMID: 37473441
Background: The artemisinins are potent and widely used antimalarial drugs that are eliminated rapidly. A simple concentration-effect pharmacometric model does not explain why dosing more frequently than once daily fails...
6.
Luangasanatip N, Painter C, Pan-Ngum W, Saralamba S, Wichaita T, White L, et al.
Vaccine
. 2023 Jun;
41(33):4854-4860.
PMID: 37365059
Thailand faced a dilemma of which groups to prioritise with a limited first tranche of COVID-19 vaccinations in early 2021, at a time when there was low incidence and low...
7.
Gomutbutra P, Kittisares A, Sanguansri A, Choosri N, Sawaddiruk P, Fakfum P, et al.
Front Artif Intell
. 2022 Oct;
5:942248.
PMID: 36277167
Data from 255 Thais with chronic pain were collected at Chiang Mai Medical School Hospital. After the patients self-rated their level of pain, a smartphone camera was used to capture...
8.
Wang Y, Luangasanatip N, Pan-Ngum W, Isaranuwatchai W, Prawjaeng J, Saralamba S, et al.
Eur J Health Econ
. 2022 Aug;
24(5):735-748.
PMID: 35951243
Objective: This study aimed to assess the cost-effectiveness of COVID-19 vaccines, preferred COVID-19 vaccine profiles, and the preferred vaccination strategies in Thailand. Methods: An age-structured transmission dynamic model was developed...
9.
Chan A, Saralamba N, Saralamba S, Ruangsittichai J, Chaisiri K, Limpanont Y, et al.
Sci Rep
. 2022 Jun;
12(1):9947.
PMID: 35705676
Next-generation sequencing technologies have accelerated the pace of helminth DNA metabarcoding research, enabling species detection in bulk community samples. However, finding suitable genetic markers with robust species-level resolution and primers...
10.
Chan A, Saralamba N, Saralamba S, Ruangsittichai J, Thaenkham U
BMC Genomics
. 2022 Feb;
23(1):104.
PMID: 35130837
Background: Genetic markers like the nuclear ribosomal RNA (rRNA) genes, internal transcribed spacer regions, mitochondrial protein-coding genes, and genomes have been utilized for molecular identification of parasitic trematodes. However, challenges...